Something old, something new: a paradigm for considering immune therapies for cardiovascular disease.
作者信息
Weber Brittany N, Blankstein Ron
机构信息
Cardiovascular Division, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.
出版信息
Cardiovasc Res. 2020 Apr 1;116(5):e51-e53. doi: 10.1093/cvr/cvaa055.
Abstract
摘要
相似文献
1
Something old, something new: a paradigm for considering immune therapies for cardiovascular disease.旧中有新：一种思考心血管疾病免疫疗法的范式。
Cardiovasc Res. 2020 Apr 1;116(5):e51-e53. doi: 10.1093/cvr/cvaa055.
2
Colchicine for the treatment of cardiovascular diseases: old drug, new targets.用于治疗心血管疾病的秋水仙碱：旧药，新靶点。
J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):1-8. doi: 10.2459/JCM.0000000000001079.
3
Colchicine in coronary disease: another renaissance of an ancient drug.秋水仙碱与冠心病：一种古老药物的再度复兴
Cardiovasc Res. 2021 Jan 1;117(1):e4-e6. doi: 10.1093/cvr/cvaa342.
4
Colchicine Use in Acute Coronary Syndromes: An Update.秋水仙碱在急性冠状动脉综合征中的应用：最新进展
Angiology. 2021 Jul;72(6):503-510. doi: 10.1177/0003319720985644. Epub 2021 Jan 8.
5
[Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].心肌梗死后的秋水仙碱治疗：秋水仙碱心血管结局试验（COLCOT）
Internist (Berl). 2020 Jul;61(7):766-769. doi: 10.1007/s00108-020-00768-2.
6
Old Drugs for New Indications in Cardiovascular Medicine.老药新用：心血管医学的新进展
Cardiovasc Drugs Ther. 2018 Apr;32(2):223-232. doi: 10.1007/s10557-018-6785-y.
7
The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease.抑制炎症在治疗动脉粥样硬化性心血管疾病中的作用。
Ann Pharmacother. 2020 Oct;54(10):1021-1029. doi: 10.1177/1060028020922994. Epub 2020 May 19.
8
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.冠心病患者使用秋水仙碱：随机试验的系统评价与荟萃分析
J Am Heart Assoc. 2021 Aug 17;10(16):e021198. doi: 10.1161/JAHA.121.021198. Epub 2021 Aug 7.
9
Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.类风湿关节炎的心血管风险及机制关联：从病理生理学到治疗。
Curr Vasc Pharmacol. 2020;18(5):431-446. doi: 10.2174/1570161117666190619143842.
10
The impact of colchicine on patients with acute and chronic coronary artery disease.秋水仙碱对急性和慢性冠状动脉疾病患者的影响。
Eur J Intern Med. 2024 Jul;125:1-9. doi: 10.1016/j.ejim.2024.01.004. Epub 2024 Jan 18.
引用本文的文献
1
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease.类风湿关节炎和动脉粥样硬化性心血管疾病的共同炎症通路。
Nat Rev Rheumatol. 2023 Jul;19(7):417-428. doi: 10.1038/s41584-023-00969-7. Epub 2023 May 25.
2
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.高血压炎症治疗靶点：从新机制到转化医学视角。
Cardiovasc Res. 2021 Nov 22;117(13):2589-2609. doi: 10.1093/cvr/cvab330.
本文引用的文献
1
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
2
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.稳定性冠心病患者低剂量秋水仙碱的疗效：LoDoCo2 试验的原理、设计和基线特征。
Am Heart J. 2019 Dec;218:46-56. doi: 10.1016/j.ahj.2019.09.011. Epub 2019 Oct 20.
3
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.低剂量甲氨蝶呤预防动脉粥样硬化事件。
N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.
4
Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.秋水仙碱在心脏疾病中的应用：从基础生物学和临床获益到心血管医学中的药物相互作用。
Curr Cardiol Rep. 2018 Jun 14;20(8):62. doi: 10.1007/s11886-018-1008-5.
5
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
6
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.美国食品药品监督管理局（FDA）强制实施市场独占权后，商业保险人群中秋水仙碱使用量的减少情况
J Gen Intern Med. 2015 Nov;30(11):1633-8. doi: 10.1007/s11606-015-3285-7. Epub 2015 Apr 9.
7
Low-dose colchicine for secondary prevention of cardiovascular disease.小剂量秋水仙碱用于心血管疾病的二级预防。
J Am Coll Cardiol. 2013 Jan 29;61(4):404-410. doi: 10.1016/j.jacc.2012.10.027. Epub 2012 Dec 19.
8
Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.秋水仙碱：其在晶体诱导性炎症中的作用机制与疗效
Curr Rheumatol Rep. 2008 Jul;10(3):218-27. doi: 10.1007/s11926-008-0036-3.
Zotero 插件